Skip to content

Treatment of stage withdrawal headaches caused by abuse drugs.

Evaluation of Medication Overuse Headache and Compression Between the Effect of Perdnisolone - nortyliptilin and prednisolone- sodium valproate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016060718479N1
Enrollment
50
Registered
2016-07-08
Start date
2016-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache caused by drug abuse. Drug-induced headache

Interventions

Intervention 1: Prednisolone 50mg/1kg for 5 days. Additionally, a random group will receive Nortriptyline 10mg every 24 hours. Intervention 2: Prednisolone 50mg/1kg for 5 days. Additionally, a random
Treatment - Drugs
Prednisolone 50mg/1kg for 5 days. Additionally, a random group will receive Nortriptyline 10mg every 24 hours
Prednisolone 50mg/1kg for 5 days. Additionally, a random group will receive Sodium Valproate 200mg every 12 hours for 2 month

Sponsors

Vice Chancellor for Research of Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 15-60 years; daily headache present on 15day/month; regular overuse for >3 month of 1 or more acute/symptomatic treatment drugs; headache has developed during medication overuse. Exclusion criteria: Age<15 years, severe systemic pathologic associated to chronic headache; major psychiatric disorder such as major depression; hypochondriasis; Contraindication or sensitivity to drugs use in study; pregnancy or lactation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Number of headache attack s. Timepoint: Before treatment, after 2 month of treatment. Method of measurement: number.;Remission headache. Timepoint: Before treatment, after 2 month of treatment. Method of measurement: Qualitative and based on the positive or negative.;The days of headache. Timepoint: Before treatment, after 2 month of treatment. Method of measurement: day.

Secondary

MeasureTime frame
Drug side effect. Timepoint: At the start of the intervention, after 2 month of treatment. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Akbar Moghadamnia

Babol University of Medical Sciences

moghadamnia@yahoo.com+98 11 3219 7667

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026